Teleflex Incorporated to Issue Quarterly Dividend of $0.34 (NYSE:TFX)

Teleflex Incorporated (NYSE:TFX) declared a quarterly dividend on Friday, May 15th. Stockholders of record on Monday, May 25th will be given a dividend of 0.34 per share by the medical technology company on Tuesday, June 30th. This represents a c) annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, May 22nd.

Teleflex has a dividend payout ratio of 9.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Teleflex to earn $10.46 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 13.0%.

Teleflex Stock Performance

NYSE:TFX opened at $133.01 on Wednesday. The stock has a 50-day simple moving average of $121.39 and a two-hundred day simple moving average of $116.69. Teleflex has a 52-week low of $100.18 and a 52-week high of $139.67. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The firm has a market capitalization of $5.89 billion, a PE ratio of -5.83, a P/E/G ratio of 0.97 and a beta of 0.82.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. During the same quarter in the prior year, the company posted $1.44 earnings per share. The business’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Analysts forecast that Teleflex will post 6.7 EPS for the current year.

Analyst Upgrades and Downgrades

TFX has been the subject of a number of recent analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research report on Friday, March 27th. Bank of America raised Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective for the company in a research report on Monday, April 13th. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and raised their price objective for the stock from $135.00 to $155.00 in a research report on Friday, May 8th. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Finally, Mizuho set a $140.00 price objective on Teleflex in a research report on Friday, May 8th. Three equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $144.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.